https://www.moneycontrol.com/news/business/earnings/sun-pharma-preview-strong-specialty-biz-robust-domestic-sales-to-boost-companys-health-in-q4-10660141.html
The company's specialty business is likely to post double-digit on-year growth in the quarter, despite some sequential moderation, according to brokerages.
Create an account or login to join the discussion